Skip to content

Drug Use-results survey for Tramcet Combination Tablets.

Drug Use-results survey for Tramcet Combination Tablets. - Drug Use-results survey for Tramcet Combination Tablets.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000015958
Enrollment
250
Registered
2014-12-15
Start date
2012-01-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after tooth extraction

Interventions

None listed

Sponsors

Janssen Pharmaceutical K.K
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with pain after tooth extraction who are treated with Tramcet combination Tablets for first time

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Safety (Adverse Drug Reaction) Effectiveness (Physician's assess)

Countries

Japan

Contacts

Public ContactHirokazu Shirai

Janssen Pharmaceutical K.K Safety Risk Management Dept.

hshirai3@ITS.JNJ.com03-4411-5951

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026